Sanofi India Financial Statements

Sanofi India (SANOFI) reported revenue of ₹20.30B in FY2024 with net income of ₹4.13B. Total assets stood at ₹16.12B and free cash flow was ₹4.25B.

Sanofi India Income Statement

Hover the chart icon for year-over-year change.

FY 2020 – FY 2024

Item	Chart	2020	2021	2022	2023	2024
Revenue		29.92B	30.31B	28.42B	29.16B	20.30B
Cost of Rev. Cost of Revenue		-12.54B	-13.07B	-11.90B	-12.01B	-9.79B
Gross Profit		17.38B	17.24B	16.52B	17.15B	10.50B
SGA Sales, General & Admin		-9.35B	-8.87B	-8.76B	-8.46B	-5.43B
Op. Income Operating Income		7.21B	7.70B	7.34B	8.29B	4.71B
PBT Profit Before Tax		6.77B	12.58B	8.64B	8.46B	4.31B
Net Income		4.78B	9.44B	6.21B	6.03B	4.13B
Dil. Shares Diluted Shares		23.03M	23.03M	23.03M	23.03M	23.03M
Diluted EPS		207.38	410.06	269.47	261.78	179.46

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Sanofi India's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Sanofi India Balance Sheet

Hover the chart icon for year-over-year change.

FY 2020 – FY 2024

Item	Chart	2020	2021	2022	2023	2024
Curr. assets Total current assets		18.33B	21.38B	16.10B	12.48B	11.27B
Non-curr. assets Total non-current assets		10.85B	9.23B	4.61B	4.67B	4.85B
Total assets		29.19B	30.61B	20.72B	17.15B	16.12B
Curr. liabilities Total current liabilities		6.87B	7.50B	7.41B	6.51B	7.19B
Non-curr. liab. Total non-current liabilities		1.13B	858.00M	553.00M	483.00M	320.00M
Total liabilities		8.00B	8.35B	7.96B	7.00B	7.51B
Total equity		21.19B	22.26B	12.76B	10.15B	8.61B
Total liab. & eq. Total liabilities & equity		29.19B	30.61B	20.72B	17.15B	16.12B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Sanofi India's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Sanofi India Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2020 – FY 2024

Item	Chart	2020	2021	2022	2023	2024
Net Income		6.77B	12.58B	8.64B	8.46B	5.62B
Operating CF Cash flow Operating Activities		6.11B	5.59B	3.99B	2.30B	4.62B
Capex Investments in PPE		-414.00M	-230.00M	-222.00M	-343.00M	-364.00M
Investing CF Cash flow Investing Activities		2.76B	6.31B	6.51B	375.00M	-192.00M
Dividend Paid		-8.04B	-8.41B	-15.73B	-8.68B	-3.85B
Financing CF Cash flow Financing Activities		-8.10B	-8.49B	-15.83B	-8.78B	-3.92B
Cash (start) Cash at beginning of period		11.20B	11.97B	15.38B	10.05B	3.95B
Cash (end) Cash at end of period		11.97B	15.38B	10.05B	3.95B	2.84B
FCF Free Cash Flow		5.70B	5.36B	3.77B	1.96B	4.25B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Sanofi India's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Dec-2024